. (a) Different controls and blanks are shown to assess the non-specific adsorption of the hcTnI to the polyestirene of the different microplates. Controls with specific antibodies (pAb220 and pAb221-B) with and without hcTnI, together with Blank 01, 02 and 03, done with a non-specific antibody as a capture antibody (Preimmune antibody) were evaluated in all the surfaces. Dark red bare correspond to the signal related to the non-specific adsorption of the biomarker to the microplate. (b) Different proteins and polymers were evaluated as an additive in the hcTnI incubation buffer step (PBS-T with additive) to minimize non-specific adsorption, following the same scheme shown in the Figure S1a [hcTnI] (ng mL -1 )
Abs, 450 nm Figure S2 . Different calibration curves for hcTnI (red plot) and hsTnI (blue plot) prepared in PBST-Casein buffer. In both cases, As220 was used as a capture antibody at dilution of 1/16000, and pAb221-B at 2.5 µg mL -1 . Each point was the average of at least two-well replicates, and the assay was run on a single day. Figure S3 . Results from the different optimization assays performed of the bioconjugates MP-pAb220 and pAb221-B. Attending to the signal-to-noise ratio (red bare), calculated as the ratio between absorbance at 1 µg mL -1 and the absorbance at 0 µg mL -1 of hcTnI, concentration of 0.1 mg mL -1 of MB-pAb220 and 0.5 µg mL -1 were chosen for develop mELISA and amperometric immunoassay. 
